Compare RIO & BME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RIO | BME |
|---|---|---|
| Founded | 1873 | N/A |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Metal Mining | Trusts Except Educational Religious and Charitable |
| Sector | Basic Materials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 140.3B | 499.8M |
| IPO Year | N/A | 2005 |
| Metric | RIO | BME |
|---|---|---|
| Price | $103.64 | $38.90 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $88.50 | N/A |
| AVG Volume (30 Days) | ★ 2.3M | 50.8K |
| Earning Date | 02-19-2026 | 01-01-0001 |
| Dividend Yield | ★ 4.14% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $10.99 | N/A |
| Revenue Next Year | $2.64 | N/A |
| P/E Ratio | $15.76 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $55.64 | $35.03 |
| 52 Week High | $112.58 | $42.74 |
| Indicator | RIO | BME |
|---|---|---|
| Relative Strength Index (RSI) | 53.39 | 43.69 |
| Support Level | $96.97 | $37.71 |
| Resistance Level | N/A | $39.52 |
| Average True Range (ATR) | 2.02 | 0.48 |
| MACD | 0.38 | 0.03 |
| Stochastic Oscillator | 45.71 | 35.51 |
Rio Tinto is a global diversified miner. Iron ore is the dominant commodity, with significantly lesser contributions from copper, aluminum, diamonds, gold, and industrial minerals. The 1995 merger of RTZ and CRA, via a dual-listed structure, created the present-day company. The two operate as a single business entity, with shareholders in each company having equivalent economic and voting rights. Major assets included the Pilbara iron ore operations, a 30% stake in the Escondida copper mine, 66%-ownership of the Oyu Tolgoi copper mine in Mongolia, the Weipa and Gove bauxite mines in Australia, and six hydro-powered aluminum smelters in Canada.
Blackrock Health Sciences Trust has an investment objective to provide total return and income mainly through long-term capital appreciation. The Trust invests the majority of its total assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives with exposure to the health sciences industry.